Nyxoah (NYXH)
(Delayed Data from NSDQ)
$10.00 USD
-0.10 (-0.99%)
Updated May 20, 2024 03:59 PM ET
After-Market: $10.00 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Price, Consensus and EPS Surprise
NYXH 10.00 -0.10(-0.99%)
Will NYXH be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for NYXH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NYXH
CareCloud, Inc. (CCLD) Reports Q1 Loss, Misses Revenue Estimates
Privia Health (PRVA) Misses Q1 Earnings and Revenue Estimates
NYXH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Inspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates
Nyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue Estimates
Pulmonx Corporation (LUNG) Reports Q3 Loss, Tops Revenue Estimates
Other News for NYXH
Analysts Offer Insights on Healthcare Companies: TransCode Therapeutics (RNAZ) and Nyxoah (NYXH)
Nyxoah reports Q1 results
OPEN, BCRX and AWIN among pre-market gainers
Nyxoah (NYXH) Gets a Buy from Piper Sandler
Analysts Are Bullish on Top Healthcare Stocks: Nyxoah (NYXH), Prestige Consumer Healthcare (PBH)